A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

How much would you pay for a limited-edition new wearable product? If you’re anything like this engineer: a pretty penny.

The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.